DOACs: 60 Second Insights

Published: 18 June 2018

  • Views:

    Views Icon 94
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 94
  • Likes:

    Heart Icon 0

Overview

Christopher Cannon and Moussa Mansour share their thoughts on DOACs in a series of 60-second interviews

Series overview

Part 1

DOACs

11 sessions

  • What are the challeges of DOACs and are alternatives needed?

    Watch now
  • What factors influence your choice of DOAC?

    Watch now
  • Do you have a DOAC you prescribe more frequently?

    Watch now
  • What are the most important anticoagulation clinical trials?

    Watch now
  • Do you have a DOAC of choice?

    Watch now
  • How important are reversal agents? - Christoper Cannon

    Watch now
  • How important are reversal agents? - Moussa Mansour

    Watch now
  • Are you once-daily or twice-daily? - Christopher Cannon

    Watch now
  • Are you once-daily or twice-daily? - Moussa Mansour

    Watch now
  • Is RCT or real-world data more important to you? - Christopher Cannon

    Watch now
  • Is RCT or real-world data more important to you? - Moussa Mansour

    Watch now

Faculty biographies